Votre recherche pour: Phenyl phosphate disodium salt

PEIpro Poster Reproducibility & Scalability Excellent lot-to-lot protein yield reproducibility using PEIpro®. Suspension HEK-293 cells were seeded at 1×106 cells/mL in serum-free medium and transfected with PEIpro® following the standard protocol....

Downstream purification for recombinant proteins With more than 30 years of chromatography experience developed products and services we have every solution to meet your needs. Our J.T.Baker® brand BAKERBOND™ chromatography resins have been used s...

Downstream purification for recombinant proteins With more than 30 years of chromatography experience developed products and services we have every solution to meet your needs. Our J.T.Baker® brand BAKERBOND™ chromatography resins have been used s...

Aurora Manufacturing Facility Core Capabilities Supply of excipients down-packed in controlled and segregated environments to meet analytical and biological requirements Custom finished goods packaging configurations including OEM packaging and la...

Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...

Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...

Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...

Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...

Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...

Montreal Manufacturing Facility The off-loading manifold at our Montreal QC manufacturing facility which includes 8600 sq. ft. for manufacturing 2200 sq. ft. for quality control and a 22800 sq. ft. warehouse. Core Capabilities Production of labora...

Back to Basics 2: Mobile Phase Selection In HPLC & UHPLC Webinar Thursday 28th January 2021 15:00 to 16:00 CEST (Berlin Paris Madrid) Replay Mobile phase composition is a fundamental decision which has a major impact on the separation of analytes ...

Microsoft Word - Grades.docx Definitions of J.T.Baker® Grades and Macron Fine Chemicals™ Grades J.T.Baker® Grades BAKER ANALYZED™ Reagent—A grade of high quality chemicals for laboratory and specialized industrial use. Every BAKER ANALYZED™ Reagen...

Upstream processing for microbial-based recombinant proteins Using microbial fermentation for the development and manufacture of recombinant proteins keeps on showing advantages e.g for the expression of proteins that do not require post-translati...

Back to Basics 2: Mobile Phase Selection In HPLC & UHPLC Webinar Thursday 28th January 2021 15:00 to 16:00 CEST (Berlin Paris Madrid) Replay Mobile phase composition is a fundamental decision which has a major impact on the separation of analytes ...

Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...

Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...